<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The study of <z:hpo ids='HP_0002667'>Wilms tumor</z:hpo>-predisposing congenital syndromes has led to the identification of one <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressor gene, WT1, and to the localization of WT2 </plain></SENT>
<SENT sid="1" pm="."><plain>Molecular genetic analyses of these and <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:hpo ids='HP_0002667'>Wilms tumors</z:hpo> have clarified the role of WT1 in <z:hpo ids='HP_0002667'>Wilms tumor</z:hpo> with <z:hpo ids='HP_0000526'>aniridia</z:hpo>, genitourinary malformations, and <z:hpo ids='HP_0001249'>mental retardation</z:hpo> (WAGR)-syndrome patients, but much remains unclear in the case of WT2 and the <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Loci on chromosomes 16q and 1p have now been implicated in the progression of <z:hpo ids='HP_0002667'>Wilms tumor</z:hpo> and may serve as molecular prognostic markers </plain></SENT>
<SENT sid="3" pm="."><plain>It is now clear that <z:hpo ids='HP_0002667'>Wilms tumors</z:hpo> are genetically <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> and may be multigenic in origin </plain></SENT>
<SENT sid="4" pm="."><plain>Molecular analyses can now be used for genetic counseling in some children and may become useful in individualizing therapy </plain></SENT>
</text></document>